Boult has been featured in the World Trademark Review’s WTR 1000 for 2026
Boult has once again been featured in the World Trademark Review’s WTR 1000 for 2026.
Subscribe to our insights here so you can keep on top of the latest IP developments and updates.
Boult has once again been featured in the World Trademark Review’s WTR 1000 for 2026.
The Brooklyn Beckham trade mark raises key questions about who controls a celebrity’s own name, the limits of the “own name” defence and the lon
We reflect on a year of life sciences innovation, highlighting Clarivate’s Drugs to Watch 2025, emerging therapy trends, AI-driven R&D and the evolv
The General Court overturned an EUIPO revocation, holding that proof of genuine use must be assessed holistically. It rejected excessive evidential bu
Partners Dr Joanna Peak and Marcus Sims are attending The Pharma & Biotech Patent Litigation Summit Europe on 19-21 January in Amsterdam.
An analysis of how the EPO Boards of Appeal and the UPC Munich Local Division assessed inventive step for Sanofi’s cabazitaxel patent and why they r
A UK court confirmed Dryrobe’s trade marks remain valid, ruling that rival D-ROBE infringed them. The case highlights the need for brand owners to p
With the Grinch leading major UK Christmas ads, brands are leveraging character merchandising and tight IP licensing to stand out in a £12bn festive
WIPO’s updated Nice Classification, effective 1 Jan 2026, reclassifies eyewear, emergency vehicles, heated clothing and essential oils. Trademark ow
A look at the dispute between Sweaty Betty and Nixi Body over similar slogans and what it reveals about trade mark limits, descriptive branding and go
A guide to recording IP assignments worldwide, outlining key requirements, risks and best practices across the UK, EUIPO/EPC, Germany, Spain and the U
The CJEU clarifies that bad-faith trade mark filings face no time limits for invalidity actions, even when earlier owners knew of the bad faith or set
Boult represented Molecular Instruments (MI) before the Hague Local Division of the Unified Patent Court (UPC).
Welcome to this series focusing on graduate careers in intellectual property (IP) and at Boult. If you’re considering a role in IP,
Angela Stephen is attending LSPN Europe in London on 1 December. The event will focus on end-to-end patent lifecycle management.
Boult has been included in Band 1 by Chambers and Partners UK for both Patents and Trade Marks in its 2026 ranking.
Alex Stephenson is attending the CIPA Life Sciences Conference in London on 20 November.
Dr Jonathan Palmer is attending APAA Malaysia 2025 on 6-10 November in Kuala Lumpur.
Partner Jo Peak and Senior Associate Farzana Miah are attending BIO-Europe 2025 in Vienna on 3-5 November.
Boult has once again been featured in the World Trademark Review’s WTR 1000 for 2026.
Boult represented Molecular Instruments (MI) before the Hague Local Division of the Unified Patent Court (UPC).
Boult has been included in Band 1 by Chambers and Partners UK for both Patents and Trade Marks in its 2026 ranking.
Once again Boult is recognised as Tier 1 for both patents and trade marks in the Legal 500 UK rankings for 2026.
Sign up to our insights so you can keep on top of the latest IP developments and updates.
SIGN UP
Boult has once again been featured in the World Trademark Review’s WTR 1000 for 2026.
Boult represented Molecular Instruments (MI) before the Hague Local Division of the Unified Patent Court (UPC).
Boult has been included in Band 1 by Chambers and Partners UK for both Patents and Trade Marks in its 2026 ranking.
Once again Boult is recognised as Tier 1 for both patents and trade marks in the Legal 500 UK rankings for 2026.
IPxNW is a leading networking event for professionals passionate about intellectual property across the North West — bringing together patent...
The Pharma & Biotech Patent Litigation Summit is a major European conference for life-sciences intellectual property professionals, focusing on patent...
LSPN Europe 2025 will focus on end-to-end patent lifecycle management, offering practical strategies for protecting and commercialising innovations in life...
The CIPA Life Sciences Conference is the leading UK event for IP professionals in the pharmaceutical, biotechnology and medical device...
APAA Malaysia 2025 will bring together IP professionals from across the Asia-Pacific region for a week of policy discussions, practical...
BIO-Europe 2025 is Europe’s premier annual partnering conference for the biotechnology, pharmaceutical and investment sectors. With over 5,000 attendees from...
The 12th Lsbc Central European Life Science Investment Conference top-level theme is: "The DNA of capital – Cracking the code...
Hosted jointly by the ABA Forum on the Entertainment & Sports Industries and the Section of Intellectual Property Law, this...
Organised by the Pharmaceutical Trademarks Group, this conference will bring together trademark professionals to discuss current challenges and opportunities in...
The Life Sciences Strategy Summit on IP & Exclusivity will convene legal and scientific experts to examine critical issues surrounding...